Home - Congruence
Congruence Therapeutics is a Montreal-based drug discovery company harnessing protein dynamics, biophysics, machine learning, and computational chemistry to design small-molecule correctors for diseases caused by protein misfolding. Its proprietary Revenir platform models the full conformational ensemble of target proteins.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountMar 2026
Sep 2025
Sep 2025
Mar 2023
Dec 2021
Create a free account to see which investors have funded this company.
Create Free Account
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
